White Paper

Aseptic Processing: How To Safely Handle APIs

Source: Chargepoint Technology
GettyImages-1222231706 global drug dev

By 2027, the global market for aseptic processing is expected to reach USD 12.5 billion. This demand has been largely driven by the increased demand for parenteral drugs, which require strict sterility procedures. Because parenteral drugs are injected directly into the bloodstream, they bypass many of the body’s natural defenses. This means that any contaminants present in the formulation can cause serious issues in aseptic processing during the manufacturing process.

So, how can pharmaceutical manufacturers work with parenteral products to ensure careful handling?

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online